World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus speaks at the 73rd World Health Assembly (WHA) at the WHO headquarters in Geneva, Switzerland, May 18, 2020. (WHO/Handout via Xinhua)
The World Health Organization Director-General Tedros Adhanom Ghebreyesus said Monday that a clinical trial of malaria drug hydroxychloroquine on COVID-19 patients came to "a temporary pause," while the safety data is reviewed by the Data Safety Monitoring Board.
"The Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the safety data is reviewed by the Data Safety Monitoring Board," Tedros told a press briefing.
